Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The hyaluronidase Hyal1 is clinically and functionally implicated in prostate cancer progression and metastasis. Elevated Hyal1 accelerates vesicular trafficking in prostate tumor cells, thereby enhancing their metastatic potential in an autocrine manner through increased motility and proliferation. In this report, we found Hyal1 protein is a component of exosomes produced by prostate tumor cell lines overexpressing Hyal1. We investigated the role of exosomally shed Hyal1 in modulating tumor cell autonomous functions and in modifying the behavior of prostate stromal cells. Catalytic activity of Hyal1 was necessary for enrichment of Hyal1 in the exosome fraction, which was associated with increased presence of LC3BII, an autophagic marker, in the exosomes. Hyal1-positive exosome contents were internalized from the culture medium by WPMY-1 prostate stromal fibroblasts. Treatment of prostate stromal cells with tumor exosomes did not affect proliferation, but robustly stimulated their migration in a manner dependent on Hyal1 catalytic activity. Increased motility of exosome-treated stromal cells was accompanied by enhanced adhesion to a type IV collagen matrix, as well as increased FAK phosphorylation and integrin engagement through dynamic membrane residence of β1 integrins. The presence of Hyal1 in tumor-derived exosomes and its ability to impact the behavior of stromal cells suggests cell-cell communication via exosomes is a novel mechanism by which elevated Hyal1 promotes prostate cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current knowledge on exosome biogenesis and release
Hessvik, N. P., & Llorente, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2595-9 · Cited by 2,362 · cited 3×
“Exosome biogenesis in tumor cells can occur through multiple routes, including the canonical inward budding of multivesicular bodies, as well as shedding from lysosomes and vesicles destined for lysosomal fusion [15, 20, 22, 23].”
BackgroundHyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., & Geuze, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20121 · Cited by 1,228
Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes
Thompson, C. A., Purushothaman, A., Ramani, V. C., Vlodavsky, I., & Sanderson, R. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.444562 · Cited by 322 · cited 2×
“Either overexpression of heparanase or treatment with exogenous heparanase increases tumor exosome secretion rate, and this phenomenon is dependent upon its catalytic activity [33].”
BackgroundEmerging Roles for Hyaluronidase in Cancer Metastasis and Therapy
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800092-2.00001-0 · Cited by 204
Self-citationZhao, N., Wang, X., Qin, L., Guo, Z., & Li, D. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.061 · Cited by 87 · cited 1×
“Low molecular weight HA (LMW-HA) polymers such as those produced by Hyal1 impact cell signaling differently than high molecular weight HA (HMW-HA) through altered affinity for cell surface receptors and also as a result of reduced multivalency, which affects binding avidity and alters local receptor clustering [12, 13…”
Background
Cited by
Nawaz, M., Shah, N., Zanetti, B. R., Maugeri, M., Silvestre, R. N., Fatima, F., Neder, L., & Valadi, H. (2018) · Cells · doi:10.3390/cells7100167 · Cited by 222
“The presence of hyaluronidase Hyal1 in prostate cancer-derived EVs stimulate the prostate stromal cell motility by engaging FAK-mediated integrin signaling, indicating that the elevated Hyal1 promotes prostate cancer progression [115].”
BackgroundThe crosstalk: exosomes and lipid metabolism
Wang, W., Zhu, N., Yan, T., Shi, Y.-N., Chen, J., Zhang, C.-J., Xie, X.-J., Liao, D.-F., & Qin, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00581-2 · Cited by 203
Emerging roles and therapeutic value of exosomes in cancer metastasis
Wu, M., Wang, G., Hu, W., Yao, Y., & Yu, X.-F. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0964-8 · Cited by 140
“have shown that prostate tumor cells can increase the mobility of stromal cells by secreting exosomes rich in hyaluronidase Hyal1, a lysosomal hyaluronidase involved in prostate cancer metastasis [29], and Chen et al.”
BackgroundNie, X., Sun, X., Wang, C., & Yang, J. (2019) · Regenerative Biomaterials · doi:10.1093/rb/rbz033 · Cited by 63
“FAK is considered to be the basic molecule of integrins dependent signal transduction pathway [23, 24].”
Background
Metadata
- Authors
- McAtee, C. O., Booth, C., Elowsky, C., Zhao, L., Payne, J., Fangman, T., Caplan, S., Henry, M. D., & Simpson, M. A.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 78-79
- Pages
- 165-179
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2799783806
- Cited by
- 72
- References
- 7
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.